Access cutting-edge thyroid cancer treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access thyroid cancer specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related thyroid cancer treatment provided free
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an increasingly recognized risk of secondary malignancies.
Sponsor: Children's Hospital of Philadelphia
Check if you qualify for this thyroid cancer clinical trial in Philadelphia, PA
If you're searching for thyroid cancer treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thyroid cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.